secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001193125-25-262188
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus Therapeutics posts updated corporate presentation; no specific material changes disclosed
--------------------------------------------------------------------------------

- Updated corporate presentation posted on company's investor relations website on November 3, 2025.
- Presentation filed as Exhibit 99.1 to the 8-K; detailed content not available in the excerpt provided.
- No financial results, pipeline updates, or guidance changes are included in the filing text.
- Routine update; no material new operational or strategic information identified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000119312525262188/0001193125-25-262188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000119312525262188/dnth-20251103.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-262188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer